Joan S. Hooper, Senior Vice President and CFO of Itron, Inc., filed a Form 4 on August 24, 2026, disclosing stock option exercises and share disposals that took place on August 20, 2026, with the issuer listed on NASDAQ:ITRI.

Key Highlights

  • Option exercise - first tranche: Hooper exercised 4,380 stock options at $68.45 per share on August 20, 2026; those options had become fully vested on June 20, 2020.
  • Option exercise - second tranche: Hooper also exercised 1,443 stock options at $69.30 per share; those options had become fully vested on February 22, 2021.
  • Tax-withholding sale: 365 shares were automatically sold at $97.8259 per share to cover tax withholding obligations associated with the vesting of a restricted stock unit award.
  • Open-market sale: 4,041 shares were sold at $98.95 per share to satisfy payment of the purchase price on the stock option exercises.
  • Remaining beneficial ownership: Following all reported transactions, Hooper directly owned 118,895 shares of Itron common stock.
  • Remaining options: After the exercises, Hooper held 7,135 options at $68.45 (expiring June 20, 2027) and 8,615 options at $69.30 (expiring February 22, 2028).

Itron CFO's August 20 Option Exercises and Share Disposals: Transaction Details

According to the filing, Joan S. Hooper, identified as SVP and CFO of Itron, Inc. (NASDAQ:ITRI), executed four separate transactions on August 20, 2026. Two of those transactions involved the exercise of previously granted stock options under transaction code "M," which the filing uses for the conversion or exercise of a derivative security.

The first option exercise covered 4,380 shares at a conversion price of $68.45, reducing the remaining balance of that grant to 7,135 options, which are set to expire on June 20, 2027. The second exercise covered 1,443 shares at $69.30, leaving 8,615 options under that grant, expiring February 22, 2028. The filing notes that the $68.45 grant became fully vested on June 20, 2020, and the $69.30 grant became fully vested on February 22, 2021. The derivative security price for both exercises is listed as $0.

On the disposition side, the filing reports two sales under transaction code "S." A total of 365 shares were automatically sold at $97.8259 to cover tax withholding obligations tied to restricted stock unit vesting. Separately, 4,041 shares were sold at $98.95 in open-market transactions, with the filing explaining these proceeds were used to satisfy the purchase price on the option exercises. The signing of the Form 4 was made by Christopher E. Ware as attorney-in-fact, dated August 24, 2026.

What Was Disclosed

Itron CFO Joan S. Hooper disclosed the exercise of two fully vested stock option tranches totaling 5,823 shares and the sale of 4,406 shares on August 20, 2026, resulting in direct beneficial ownership of 118,895 shares of Itron common stock.